l carnitine tmao nature medicine 2013 koeth Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy Comparison of short-term and long-term

Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications The microbial metabolite trimethylamine N oxide promotes antitumor immunity in triple negative breast cancer: Cell Metabolism Gut Microbiome Derived Metabolite Trimethylamine N Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans Hypertension Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Intestinal microbiota metabolism of L carnitine, a nutrient in red meat, promotes atherosclerosis PMC L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP ScienceDirect

SKU: 75729397498 · From sff-camara.com